GlassScriptPhysician profile
M Arif Hashmi
NPI 1497743975
$4,065.92
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,123 · 2020: $940 · 2021: $1,520 · 2022: $483.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $795.56 | 2019-2022 | |
| Abbvie INC. | $629.90 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $531.89 | 2019-2022 | |
| Janssen Biotech, INC. | $498.04 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $257.46 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $196.37 | 2019-2021 | |
| Pfizer INC. | $188.67 | 2019-2021 | |
| Qol Medical, LLC | $188.33 | 2019-2021 | |
| Celgene Corporation | $124.59 | 2021-2022 | |
| Gilead Sciences, INC. | $117.69 | 2019-2022 | |
| Daiichi Sankyo INC. | $108.13 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $75.83 | 2021-2022 | |
| Ucb, INC. | $73.06 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $69.28 | 2019-2021 | |
| Vivus LLC | $44.57 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $42.49 | 2020 | |
| Intercept Pharmaceuticals, INC. | $26.32 | 2019 | |
| Braintree Laboratories, INC. | $25.55 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $17.53 | 2021 | |
| Evoke Pharma, INC. | $14.70 | 2021 | |
| Allergan, INC. | $14.28 | 2020 | |
| Amgen INC. | $13.80 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.88 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw M Arif Hashmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.